LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it has withdrawn its marketing authorisation application for its advanced ovarian cancer maintenance therapy Votrient in the EU. The application was in relation to an additional indication of the treatment of women with FIGO stag Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br />FTSE 100 - WINNERS<br /><br /><strong>Babcock</strong> International Group, up 3.5%. The company said its Cavendish Fluor Partnership has Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Babcock</strong> International Group PLC said its Cavendish Fluor Partnership has been selected as the preferred bidder in the competitio Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday announced a series of new investments in sub-Saharan Africa of up to GBP130 million over the next five years to increase access to medicines, build its capacity and contribute to its long-term business growth. Glaxo said it plans to build Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its Phase III STABILITY study for darapladib in the treatment of patients with chronic coronary heart disease failed to meet its primary endpoint, although it said that the effects of the drug on the reduction of coronary events was of Read More
LONDON (Alliance News) - Shares have opened higher Monday ahead of a week with a full calendar of economic data reports scheduled.<br /><br /><strong>Rolls-Royce</strong> Holdings PLC said it has won a deal worth more than USD50 million to support the US Marines Corps' fleet of KC-130J air-to- Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that it had acquired full ownership of its Indonesian Consumer Healthcare business for IDR465 billion, equivalent to GBP24.6 million, and sold its non-core brand and manufacturing facility in the country. The company bought the remain Read More
LONDON (Alliance News) - NASDAQ-listed Myland Inc said Thursday that it has won its breach of contract case against UK pharmaceutical giant GlaxoSmithKline PLC. The jury of the United States District Court for New Jersey decided that Glaxo owes Mylan USD106.7 million in damages, over charge Read More
CANONSBURG (Alliance News) - Mylan Inc. said Thursday that, after a trial in the US District Court for the District of New Jersey, a jury returned a verdict in favour of Mylan in its breach of contract lawsuit against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release or ER Tab Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday announced a new research collaboration with the European Bioinformatics Institute and the Wellcome Trust Sanger Institute, to harness 'big data' and genome sequencing to improve the success rate for discovering new medicines. The three w Read More
LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of <strong>Lloyds Banking</strong> Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had withdrawn its European marketing authorisation application for the combined use of Meikinist and Tafinlar for the treatment of unresectable or metastatic melanoma with a BRAF V600 mutation. This was as a result of the Commit Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br /><strong>----------</strong><br /><strong>COMPANIES</strong><br />----------<br />The UK government said it has raised GBP4.2 billion in its sale of a second tranche of <strong>Lloyds Banking</strong> Group Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had withdrawn its marketing authorisation application for the combined use of Meikinist and Tafinlar for the treatment of unresectable or metastatic melanoma with a BRAF V600 mutation in Europe. This was as a result of the Commi Read More
LONDON (Alliance News) - UK equities are attempting to rebalance today in the wake of the tax and regulatory changes unveiled in Wednesday's government budget.<br /><br />Life insurance companies have continued to take a battering during morning trading, following the announcement by Chancello Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Next</strong>, up 1.9%. The homeware and clothing retailer reported higher profi Read More
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Next</strong> PLC reported higher profits and revenues for the financial year ended January 2014 driven by its online business, raised Read More
LONDON (Alliance News) - Shares have opened lower Thursday, as markets around the world react to Fed Chair Janet Yellen's hint of an earlier-than-expected rise in US interest rates. The CEO of handbag firm <strong>Mulberry</strong> has stepped down after only two years in the job. <br /> Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said that a late stage trial of its MAGE-A3 cancer immunotherapeutic for patients with non-small-cell lung cancer did not meet two of its co-primary endpoints, as it failed to extend disease-free survival compared to a placebo. It did no Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br /><strong>----------</strong><br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE CUTS HSBC TO 'UNDERPERFORM' ('OUTPERFORM,') - PRICE TARGET 580 (780) PENCE <br />----------<br Read More